as 07-26-2024 4:00pm EST
INVO Bioscience Inc operates a healthcare services fertility company. Assisted Reproductive Technology (ART) marketplace by making fertility care more accessible and inclusive to people. Its commercial strategy is focused on operating fertility-focused clinics, which includes the opening of dedicated INVO Centers offering the INVOcell and IVC procedure (with three centers in North America now operational) and the acquisition of US-based, profitable in vitro fertilization (IVF) clinics. The company sells its products to physicians directly; and IVF centers, medical practices, and physicians through distributors.
Founded: | 2007 | Country: | United States |
Employees: | N/A | City: | SARASOTA |
Market Cap: | 3.4M | IPO Year: | N/A |
Target Price: | N/A | AVG Volume (30 days): | 40.2K |
Analyst Decision: | N/A | Number of Analysts: | N/A |
Dividend Yield: | N/A | Dividend Payout Frequency: | N/A |
EPS: | -3.55 | EPS Growth: | N/A |
52 Week Low/High: | $0.50 - $7.20 | Next Earning Date: | 08-12-2024 |
Revenue: | $4,248,836 | Revenue Growth: | 321.67% |
Revenue Growth (this year): | 185.11% | Revenue Growth (next year): | 148.37% |
INVO Breaking Stock News: Dive into INVO Ticker-Specific Updates for Smart Investing
CNW Group
2 months ago
ACCESSWIRE
2 months ago
Business Insider
2 months ago
GlobeNewswire
2 months ago
Motley Fool
2 months ago
CNW Group
2 months ago
AFP
2 months ago
Business Insider
2 months ago
The information presented on this page, "INVO INVO BioScience Inc. - Stocks Price | History | Analysis", including historical data, forecasts, news, insider information, and predictions, is provided for educational purposes only. It should not be considered as financial advice or a recommendation to buy or sell any securities. Decisions regarding investments should be made only after careful consideration and consultation with a qualified financial advisor. We do not endorse or guarantee the accuracy or reliability of the information provided, and we disclaim any liability for financial losses incurred as a result of decisions made based on the information presented.